Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Prostate Cancer

Free Subscription 19.10.2026 7 BJU Int 1 BMC Cancer 1 BMC Urol 2 Eur J Radiol 1 Eur Radiol 1 Eur Urol 1 Int J Urol 1 J Clin Oncol 1 J Natl Cancer Inst 1 J Urol 1 Nat Rev Urol 1 PLoS One 3 Prostate 1 Radiol Imaging Cancer 1 Radiology

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

BJU Int

1. 
   Recent advances in the management of prostate cancer.
   BJU Int. 2026;138:745-746.
   PubMed        
   
   
2. WANG E, Wei X, Dua Y, Perera M, et al
   Transurethral ultrasound ablation (TULSA) for prostate cancer: a systematic review and meta-analysis.
   BJU Int. 2026 Oct 12. doi: 10.1111/bju.70471.
   PubMed         Abstract available
   
   
3. CAMERON A, Miller L
   Variation in PSA level referral thresholds for suspected prostate cancer across NHS trusts in England.
   BJU Int. 2026 Oct 16. doi: 10.1111/bju.70506.
   PubMed        
   
   
4. FERNANDEZ-CONEJO G, Gonzalez Alvarez C, Del Olmo Duran P, Tagalos Munoz A, et al
   Learning curve of Versius-assisted radical prostatectomy: role of prior experience and proctoring.
   BJU Int. 2026;138:905-914.
   PubMed         Abstract available
   
   
5. VOLLEMAERE J, Bastian J, Mink J, Wagenpfeil G, et al
   Off-midline versus supraumbilical specimen extraction sites in robot-assisted radical prostatectomy.
   BJU Int. 2026;138:886-893.
   PubMed         Abstract available
   
   
6. FUJIWARA S, Fukumoto K, Takeuchi M, Konnai Y, et al
   AI-based anatomical recognition for bladder neck dissection in robot-assisted radical prostatectomy.
   BJU Int. 2026;138:852-859.
   PubMed         Abstract available
   
   
7. SEARS C, Watson R, Brown E, Abbas B, et al
   Gynaecomastia secondary to transdermal oestradiol used for androgen deprivation therapy: informed reality vs subjective fear.
   BJU Int. 2026;138:815-821.
   PubMed         Abstract available
   
   

   
   BMC Cancer

8. ZHANG J, Zhang A, Tian J, Wang S, et al
   Neutropenia events with androgen receptor pathway inhibitor-containing versus control therapies in prostate cancer patients: a systematic review and meta-analysis.
   BMC Cancer. 2026;26:1222.
   PubMed         Abstract available
   
   

   
   BMC Urol

9. WANDIRA EG, Asiimwe P, Nanyiri J, Ainembabazi AT, et al
   Uptake of prostate biopsy and its associated factors among patients previously confirmed to have elevated prostate-specific antigen levels at Kyabirwa surgical center, Jinja city: a cross-sectional study.
   BMC Urol. 2026;26:248.
   PubMed         Abstract available
   
   

   
   Eur J Radiol

10. HUANG J, Zhang Y, Yang O, Feng Q, et al
    Periprostatic adipose tissue imaging in prostate cancer: Imaging phenotypes, task-specific spatial strategies, and multicompartment integration-a critical review.
    Eur J Radiol. 2026;206:113296.
    PubMed         Abstract available
    
    
11. KYLE ET, Sweeney KJ, McCabe DH, O'Sullivan NJ, et al
    MRI-derived radiomics for prostate cancer active surveillance: a systematic review.
    Eur J Radiol. 2026;205:113291.
    PubMed         Abstract available
    
    

    
    Eur Radiol

12. BREMBILLA G, Messina E, Barret T, Caglic I, et al
    Prostate cancer screening with MRI: insights from the ESUR Prostate MRI Working Group.
    Eur Radiol. 2026 Oct 15. doi: 10.1007/s00330-026-12863.
    PubMed         Abstract available
    
    

    
    Eur Urol

13. KISHAN AU, Wilhalme H, Felix C, Enke J, et al
    (177)Lu-Prostate-specific Membrane Antigen Prior to Stereotactic Ablative Radiotherapy in Oligorecurrent Prostate Cancer: Secondary and Exploratory End Point Results from the Randomized Phase 2 LUNAR Trial.
    Eur Urol. 2026 Oct 12:S0302-2838(26)02376-6. doi: 10.1016/j.eururo.2026.
    PubMed         Abstract available
    
    

    
    Int J Urol

14. NISHINO T, Shimbo M, Oguchi T, Sano M, et al
    Impact of Prior Holmium Laser Enucleation of the Prostate on Outcomes After Robot-Assisted Radical Prostatectomy.
    Int J Urol. 2026;33:e70651.
    PubMed         Abstract available
    
    

    
    J Clin Oncol

15. SOLANKI AA, Adams W, Proudfoot JA, Baldea K, et al
    Dose-Escalated Focal Salvage High-Dose-Rate Brachytherapy and Genomic Classifier Risk Stratification in Radiorecurrent Prostate Cancer: The F-SHARP Phase I/II Clinical Trial.
    J Clin Oncol. 2026 Oct 14:JCO2502730. doi: 10.1200/JCO-25-02730.
    PubMed         Abstract available
    
    

    
    J Natl Cancer Inst

16. VAN DER VELDEN KJM, Bosch D, van den Wildenberg AM, Bergman AM, et al
    Trends in bone health agent use and skeletal events in metastatic castration-resistant prostate cancer.
    J Natl Cancer Inst. 2026 Oct 13:djag385. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    J Urol

17. TOSOIAN JJ, Penson DF, Ross AE, Salami SS, et al
    Reply: Noninvasive Urine Test Predicts Grade Group Upgrading in Patients on Active Surveillance for Prostate Cancer: Multisite Validation and Comparison With MRI.
    J Urol. 2026 Oct 15:101097JU0000000000005332. doi: 10.1097/JU.0000000000005332.
    PubMed        
    
    

    
    Nat Rev Urol

18. BERNARDINO RM, Lobo J, Schwen Z, van der Kwast T, et al
    Cribriform and intraductal carcinoma in prostate cancer - implications for risk stratification and therapeutic decision-making.
    Nat Rev Urol. 2026 Oct 9. doi: 10.1038/s41585-026-01189.
    PubMed         Abstract available
    
    

    
    PLoS One

19. MURTHY S, Fago K, Knight J, Kowalczyk K, et al
    Personalized genomic landscape of prostate cancer in African American men reveals novel drivers and therapeutic opportunities.
    PLoS One. 2026;21:e0360389.
    PubMed         Abstract available
    
    

    
    Prostate

20. BASHI T, Rubinstein Y, Kidron A, Marom R, et al
    Natural History of PI-RADS 3 Lesions on Serial Prostate mpMRI.
    Prostate. 2026;86:1500-1507.
    PubMed         Abstract available
    
    
21. LO E, Clein A, Tam M, Trimble S, et al
    Circulating Tumor Cell Synaptophysin and Androgen Receptor Expression Reflect Prostate Cancer Phenotypes in Metastatic Disease.
    Prostate. 2026 Oct 11. doi: 10.1002/pros.70267.
    PubMed         Abstract available
    
    
22. INCORVAIA L, Mollica V, Fiala O, Fujita K, et al
    Real-World HRR Testing Pathways and Patterns of Detected Alterations in Prostate Cancer From the Multinational ARON-3 Study.
    Prostate. 2026 Oct 12. doi: 10.1002/pros.70269.
    PubMed         Abstract available
    
    

    
    Radiol Imaging Cancer

23. PONSIGLIONE A, Cereser L, De Martino M, Bacchetti E, et al
    Risk-adapted MRI Protocols for the Detection of Clinically Significant Prostate Cancer.
    Radiol Imaging Cancer. 2026;8:e260124.
    PubMed         Abstract available
    
    

    
    Radiology

24. SAHA A, Bosma JS, Twilt JJ, Ng ABCD, et al
    Artificial Intelligence for Prostate Cancer Detection and Screening on MRI in Global Populations: The SCARLET-1 Study.
    Radiology. 2026;321:e262081.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Prostate Cancer is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum